Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients.
Arch Dermatol. 2012 Sep 1; 148(9):1031-6
Detlef Zillikens and Enno Schmidt
18 Jul 2012
|
Confirmation
This study corroborates previous reports from other countries that rituximab is an effective adjuvant treatment for severe pemphigus. Importantly, the study suggests that the use of rituximab in the earlier phase of the disease may result in a better clinical outcome.
Several cohort studies, including larger numbers of patients...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.